Cipla declines on the BSE

21 Feb 2025 Evaluate

Cipla is currently trading at Rs. 1476.10, down by 3.70 points or 0.25% from its previous closing of Rs. 1479.80 on the BSE.

The scrip opened at Rs. 1489.95 and has touched a high and low of Rs. 1501.05 and Rs. 1470.30 respectively. So far 13708 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1702.00 on 09-Oct-2024 and a 52 week low of Rs. 1317.60 on 10-May-2024.

Last one week high and low of the scrip stood at Rs. 1501.05 and Rs. 1422.75 respectively. The current market cap of the company is Rs. 118945.53 crore.

The promoters holding in the company stood at 29.19%, while Institutions and Non-Institutions held 54.28% and 16.52% respectively.

United States Food and Drugs Administration (USFDA) has concluded a current Good Manufacturing Practices (cGMP) inspection at Cipla’s wholly owned subsidiary -- Sitec Labs’ (Sitec) analytical testing facility located in Mahape, Navi Mumbai. The inspection conducted from February 18, 2025 to February 20, 2025.

On conclusion of the inspection, Sitec received two observations in Form 483. The Company will work closely with the USFDA and remains committed to address these observations comprehensively within stipulated time.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1452.70 8.15 (0.56%)
02-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1714.25
Dr. Reddys Lab 1149.75
Cipla 1452.70
Lupin 2009.40
Zydus Lifesciences 891.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...